• Publications
  • Influence

Claim Your Author Page
Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage publications (all current information on this profile has been aggregated automatically from publisher and metadata sources).
  • Sebastián Rufián, Francisco Cristóbal Muñoz-Casares, +8 authors Carlos Pera
  • Medicine
  • Journal of surgical oncology
  • 2006 (First Published: 15 September 2006)
  • BACKGROUND AND OBJECTIVES Advanced ovarian cancer typically spreads in a diffuse intra-abdominal fashion. This characteristic suggests that combined radical surgery and intraperitoneal chemotherapyContinue Reading
  • Francisco Cristóbal Muñoz-Casares, Sebastián Rufián, +6 authors Jordi Muntané
  • Medicine
  • Clinical & translational oncology : official…
  • 2009 (First Published: 1 November 2009)
  • Background and objectivesPeritoneal carcinomatosis in women frequently has an ovarian origin. Hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) along with radical surgery/peritonectomyContinue Reading
  • Francisco Cristóbal Muñoz-Casares, Sebastián Rufián, +9 authors Enrique Aranda
  • Medicine
  • Cancer Chemotherapy and Pharmacology
  • 2011 (First Published: 1 July 2011)
  • PurposeThe admitted benefits of intraperitoneal chemotherapy during postoperative administration for the treatment of peritoneal carcinomatosis from ovarian origin are limited by their associatedContinue Reading
  • Álvaro Arjona-Sánchez, A Cadenas-Febres, +6 authors Sebastián Rufián-Peña
  • Medicine
  • European journal of surgical oncology : the…
  • 2016 (First Published: 1 June 2016)
  • BACKGROUND The acute renal dysfunction (ARD) is a common complication in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC). Our aim is evaluate the ARD post-HIPEC proceduresContinue Reading
  • Francisco Cristóbal Muñoz-Casares, Sebastián Rufián, +14 authors Alberto Gómez-Portilla
  • Medicine
  • Clinical & translational oncology : official…
  • 2007 (First Published: 1 October 2007)
  • Peritoneal carcinomatosis, considered years ago as a final stage of unresectable cancer, can now be managed with curative intention by means of a radical cytoreductive surgical procedure withContinue Reading
  • Francisco Cristóbal Muñoz-Casares, F J Medina-Fernández, +7 authors Francisco Javier Briceño
  • Medicine
  • European journal of surgical oncology : the…
  • 2016 (First Published: 1 February 2016)
  • BACKGROUND Cytoreductive surgery with peritonectomy procedures and hyperthermic intraperitoneal chemotherapy (CRS + HIPEC) represents a radical therapeutic approach to achieve complete cytoreductionContinue Reading
  • Francisco Javier Medina Fernández, Francisco Cristóbal Muñoz-Casares, +6 authors Javier Briceño Delgado
  • Medicine
  • Annals of Surgical Oncology
  • 2014 (First Published: 1 April 2015)
  • AbstractBackgroundInflammatory markers may help monitor postoperative evolution of surgical patients and detect complications. However, to date, the effect that neoadjuvant chemotherapy andContinue Reading
    Colorectal peritoneal carcinomatosis was considered a terminal condition with a merely palliative treatment that included only supportive care, palliative surgery and the best systemic chemotherapy.Continue Reading
  • Álvaro Arjona-Sánchez, Francisco Cristóbal Muñoz-Casares, +9 authors Sebastián Rufián-Peña
  • Medicine
  • World Journal of Surgery
  • 2013 (First Published: 1 June 2013)
  • BackgroundPseudomyxoma peritonei (PMP) is a rare disease with an incidence rate of approximately 1 per million a year. During the past few years, there has been a survival benefit for these patientsContinue Reading